Chung Looi

Chung Looi PhD is the CEO of Ablatus Therapeutics, a women-led MedTech company in Cambridge, UK. Ablatus developed a patented enhanced ablation technology that can treat cancerous and non-cancerous tumours like fibroids, a condition that affects millions of women worldwide.

She is a scientist turned entrepreneur by training, where she completed her PhD in Experimental Psychology from the University of Oxford and spent the last decade in commercial roles bringing medical devices to global markets. Previously, Looi led strategic partnerships with life sciences, commercial insurers, research organisations, and health systems in the US, Asia, and EMEA to bring cutting-edge medical devices from the UK and Denmark to global markets. At Ablatus, Looi leads the vision, strategy, and fundraising to bring Luna, a minimally invasive, fertility-preserving, and inclusive treatment to patients worldwide. Driven by a passion for leveraging technology to improve healthcare outcomes, Looi is dedicated to promoting equality, diversity, and inclusivity within the life sciences.